title: Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health.
authors.affiliation: Department of Internal Medicine and the Robert Wood Johnson Clinical Scholars Program, University of Michigan, Ann Arbor, MI, USA.
authors.forename: Rodney A
authors.initials: RA
authors.lastname: Hayward
authors.forename: Harlan M
authors.initials: HM
authors.lastname: Krumholz
mesh_terms: D000328:Adult; D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002784:Cholesterol / Q000378:metabolism; D019317:Evidence-Based Medicine; D006801:Humans; D050356:Lipid Metabolism / Q000187:drug effects; D008077:Lipoproteins, LDL / Q000037:antagonists & inhibitors*; D008297:Male; D008659:Metabolic Diseases / Q000188:drug therapy*; D058990:Molecular Targeted Therapy; D054555:National Heart, Lung, and Blood Institute (U.S.); D009316:National Institutes of Health (U.S.); D017410:Practice Guidelines as Topic; D057285:Precision Medicine; D014481:United States
chemical_list: D000924:Anticholesteremic Agents; D008077:Lipoproteins, LDL; D002784:Cholesterol